Featured Research

from universities, journals, and other organizations

Scientists Develop Powerful Tool For Studying TB

Date:
September 30, 1997
Source:
NIH-National Institute Of Allergy And Infectious Diseases
Summary:
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have developed a technique that theoretically will allow researchers to study the function of every gene in the bacterium that causes tuberculosis (TB). The finding, reported in the Sept. 30, 1997 issue of the Proceedings of the National Academy of Sciences (PNAS), has significant implications for the development of new TB drugs and vaccines and for advancing our understanding of how TB bacteria cause disease.

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have developed a technique that theoretically will allow researchers to study the function of every gene in the bacterium that causes tuberculosis (TB). The finding, reported in the Sept. 30, 1997 issue of the Proceedings of the National Academy of Sciences (PNAS), has significant implications for the development of new TB drugs and vaccines and for advancing our understanding of how TB bacteria cause disease.

"This is a major advance for the TB research community and it represents an important step in NIAID's efforts to develop research-based solutions to one of our foremost global health problems," says NIAID Director Anthony S. Fauci, M.D. "One-third of the world's population is infected with Mycobacterium tuberculosis (M.tb), the organism that causes TB. Each year, an estimated 3 million people die from TB, more than from any other infectious disease."

TB bacteria are notoriously difficult organisms to study in the laboratory. Many of the molecular techniques that scientists use routinely to analyze other microorganisms have until recently been of little use in TB research. Consequently, systematic methods for creating mutations in M.tb genes have eluded scientists. Such methods are extremely valuable in the study of disease pathogens, as they allow scientists to examine the effect of individual gene mutations on an organism's ability to grow or cause disease. These studies can reveal new drug targets or identify potential vaccine candidates.

"Analyses of M.tb have been hampered by the lack of efficient systems for transferring new genetic material into this pathogen," explains William R. Jacobs, Jr., Ph.D., senior author of the study.

"Furthermore, because M.tb is such a slow-growing bacterium, methods of creating and analyzing mutations that involve exposing cells to DNA-damaging agents, and then characterizing colonies arising from single cells, are of limited value."

Dr. Jacobs, an NIAID grantee at the Howard Hughes Medical Institute (HHMI) at Albert Einstein College of Medicine in the Bronx, N.Y., led a research team that found an efficient way to create mutations in TB genes using fragments of DNA known as transposons. Transposons insert themselves at random into bacterial DNA, inactivating any gene in which they take up residence.

Scientists have used transposon mutagenesis, as this process is called, to generate vast numbers of mutations in many other kinds of bacteria. These so-called mutation libraries allow scientists to study the function of individual bacterial genes. Until now, transposon mutagenesis has not been feasible in TB bacteria.

Dr. Jacobs, NIAID grantees Barry R. Bloom, Ph.D., also of HHMI at Albert Einstein College of Medicine, and Graham F. Hatfull, Ph.D., of the University of Pittsburgh, and their colleagues constructed special delivery vectors to carry transposons inside TB cells. Known as conditionally replicating shuttle phasmids, these vectors essentially are genetically engineered mycobacteriophages -- viruses that infect M.tb and related bacteria. For this study, the researchers developed phasmids with mutations that prevented them from replicating at a temperature of 37 degrees Celsius (C). The transposons carried by these shuttle phasmids contained a gene conferring resistance to the antibiotic kanamycin.

The researchers mixed M.tb cells with the transposon-bearing shuttle phasmids and incubated them at 37 C. Instead of replicating repeatedly and destroying the M.tb cells, at this "non-permissive" temperature the phasmids simply stuck to and entered the bacterial cells, providing an opportunity for the transposons to insert themselves into the bacterial DNA.

To determine the success of their efforts, the researchers transferred the TB-phasmid mixture to culture media containing kanamycin. Only those TB bacteria carrying the kanamycin resistance gene, by virtue of having undergone transposon mutagenesis, will grow on this media. Dr. Jacobs and his colleagues recovered thousands of kanamycin-resistant M.tb mutants in three separate experiments.

"Analyses of DNA from randomly selected kanamycin-resistant M.tb colonies revealed a random distribution of the transposon insertions," says Dr. Jacobs, "suggesting that the mutants obtained in our experiments represent libraries of independent mutants of M.tb."

In the same issue of PNAS, researchers from France's Pasteur Institute describe an alternative method for performing transposon mutagenesis in M.tb, which also results in the production of thousands of mutants. Dr. Jacobs also is a co-author of that study.

"With these techniques, researchers theoretically should be able to create mutations in virtually every gene of Mycobacterium tuberculosis," adds Ann Ginsberg, M.D., Ph.D., NIAID's TB program officer. "This should provide an unprecedented opportunity to make rapid and substantial progress in the understanding of pathogenesis and development of novel therapeutics and vaccines for TB."

In addition to Drs. Jacobs, Bloom and Hatfull, collaborators on the NIAID-funded study include Stoyan Bardarov, M.D., Ph.D., Jordan Kriakov, M.D., Ph.D., Christian Carriere, M.D., Ph.D., Shengwei Yu, and Carlos Vaamonde, M.D., of Albert Einstein College of Medicine; and Ruth A. McAdam, Ph.D., of the Central Veterinary Laboratory in Surrey, Great Britain.

NIAID, a component of the National Institutes of Health (NIH), supports research on AIDS and other sexually transmitted diseases, tuberculosis and malaria, as well as allergies and asthma. NIH is an agency of the U.S. Department of Health and Human Services.


Story Source:

The above story is based on materials provided by NIH-National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

NIH-National Institute Of Allergy And Infectious Diseases. "Scientists Develop Powerful Tool For Studying TB." ScienceDaily. ScienceDaily, 30 September 1997. <www.sciencedaily.com/releases/1997/09/970930052021.htm>.
NIH-National Institute Of Allergy And Infectious Diseases. (1997, September 30). Scientists Develop Powerful Tool For Studying TB. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/1997/09/970930052021.htm
NIH-National Institute Of Allergy And Infectious Diseases. "Scientists Develop Powerful Tool For Studying TB." ScienceDaily. www.sciencedaily.com/releases/1997/09/970930052021.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Obama Orders Military Response to Ebola

Obama Orders Military Response to Ebola

AP (Sep. 16, 2014) Calling the Ebola outbreak in West Africa a potential threat to global security, President Barack Obama is ordering 3,000 U.S. military personnel to the stricken region amid worries that the outbreak is spiraling out of control. (Sept. 16) Video provided by AP
Powered by NewsLook.com
UN: 20,000 Could Be Infected With Ebola by Year End

UN: 20,000 Could Be Infected With Ebola by Year End

AFP (Sep. 16, 2014) Nearly $1.0 billion dollars is needed to fight the Ebola outbreak raging in west Africa, the United Nations say, warning that 20,000 could be infected by year end. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Obama: Ebola Outbreak Threat to Global Security

Obama: Ebola Outbreak Threat to Global Security

AP (Sep. 16, 2014) President Obama is ordering U.S. military personnel to West Africa to deal with the Ebola outbreak, which is he calls a potential threat to global security. (Sept. 16) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins